Causal Effects Between Neurodegenerative Diseases, Metabolites, and Brain Volume | Synapse
March 3, 2026
Causal Effects Between Neurodegenerative Diseases, Metabolites, and Brain Volume
Key Points
Hippocampal volumes are affected by metabolites like nervonoylcarnitine and 1-linoleoyl-2-arachidonoyl-GPC.
Specifically, the ratio of retinol to linoleoyl-arachidonoyl-glycerol affects only Lewy Body Dementia (LBD).
This analysis explores the links between neurodegenerative diseases and specific brain metabolites.
Understanding these relationships could lead to targeted treatments for dementia and related disorders.
Abstract
Nervonoylcarnitine and 1-linoleoyl-2-arachidonoyl-GPC may mediate the predicted effects of AD and LBD on hippocampal volumes, while the ratio of retinol to linoleoyl-arachidonoyl- glycerol mediates only LBD.